|
Roche is on a roll. The company operates two segments, pharmaceuticals and diagnostics, and sells its products in more than 150 countries. Roche's prescription drugs include cancer therapies MabThera/Rituxan and Herceptin, anemia treatment NeoRecormon/Epogin, hepatitis drug Pegasys, transplant drug CellCept, obesity treatment Xenical, and Tamiflu, which is used to prevent and treat influenza, including avian strains. The company markets many of its bestsellers through subsidiary Genentech and affiliate Chugai Pharmaceutical. Roche's diagnostics arm offers advanced DNA tests, diabetes monitoring supplies, and point-of-care diagnostics used in a variety of health care settings.
|
| | | Contact Information | |
Address: |
Grenzacherstrasse 124
CH-4070 Basel, Switzerland
| | Phone: | +41-61-688-11-11 | | Fax: | +41-61-691-93-91 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 45355.50 M | | Revenue Growth (1 yr): | 10.80% | | Employees (2007): | 78,604 | | Employee Growth (1 yr): | 5.70% |
|
|
Key People
| | • |
Chairman:
Franz B. Humer
| | • |
CEO Roche Group:
Severin Schwan
| | • |
CFO and Deputy Head Corporate Executive Committee:
Erich Hunziker
|
|
|
